Advanced glycation end products and diabetic complications
- 1 September 2002
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 11 (9) , 1205-1223
- https://doi.org/10.1517/13543784.11.9.1205
Abstract
Diabetic complications are major cause of morbidity and mortality in patients with diabetes. While the precise pathogenic mechanism(s) underlying conditions such as diabetic retinopathy, diabetic nephropathy and increased risk of atherosclerosis remain ill-defined, it is clear that hyperglycaemia is a primary factor that initiates and promotes complications. Formation of advanced glycation end products (AGEs) correlate with glycaemic control, and these reactive adducts form on DNA, lipids and proteins where they represent pathophysiological modifications that precipitate dysfunction at a cellular and molecular level. Many of these adducts form rapidly during diabetes and promote progression of a raft of diabetes-related complications. Recent evidence also suggests an important interaction with other pathogenic mechanisms activated within the diabetic milieu. This review outlines the nature of AGE formation in biological systems and highlights accumulative evidence that implicates these adducts in diabetic...Keywords
This publication has 133 references indexed in Scilit:
- Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantationJournal of Hepatology, 2002
- Advanced Glycation End Products-Induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor in Bovine Retinal PericytesBiochemical and Biophysical Research Communications, 2002
- Plasma levels of advanced glycation end products in children with renal diseasePediatric Nephrology, 2001
- Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation ReactionsBiochemical and Biophysical Research Communications, 1999
- Characterization of the Advanced Glycation End-Product Receptor Complex in Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- Ribozyme Targeting of Receptor for Advanced Glycation End Products in Mouse Mesangial CellsBiochemical and Biophysical Research Communications, 1998
- Immunochemical Evidence for Increased Formation of Advanced Glycation End Products and Inhibition by Aminoguanidine in Diabetic Rat LensesBiochemical and Biophysical Research Communications, 1997
- Advanced Glycation End Products Induce Expression of Vascular Endothelial Growth Factor by Retinal Müller CellsBiochemical and Biophysical Research Communications, 1997
- The Inhibition of Sugar-Induced Structural Alterations in Collagen by Aspirin and Other CompoundsBiochemical and Biophysical Research Communications, 1994
- Predisposition to Hypertension and Susceptibility to Renal Disease in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988